Skip to content.
|
Skip to navigation
Personal tools
Log in
Search Site
only in current section
Advanced Search…
Sections
Home
About Us
Our People
Our Vision
Contact Us
Translational Research
Discovery
Pre-Clinical
Clinical Trials
Health Services
Publications
Software
miRDeep*
RNASeqBrowser
Bicluster
miRPlant
J-Circos
Presentations 2019
Presentations 2018
Presentations 2017
Presentations 2016
Presentations 2015
Presentations 2014
Presentations 2013
Linkages
News
Events
Upcoming Events
Previous Events
Get Involved
Support Our Research
Prostate Cancer Information
PCOR-QLD
About PCOR-QLD
Meet the Team
Our Research
Our Partners
For Participants
If I do not wish to participate
For Clinicians
For Hospitals and Clinics
For Researchers
Useful Links
Contact Us
DONATE
Translational Research
Info
Discovery
Program Grants
Revolutionary Team Award - Adaptive Response to Targeting the Androgen Axis: A Strategic Offensive on Resistance
2014 - 2019
Establishment of the Australian Prostate Cancer Research Centre – Queensland
2009 - 2019
Revolutionary Team Award 3 - exploiting alterations in lipid metabolism to improve diagnosis, treatment and molecular imaging of prostate cancer
2015 - 2018
Australian-Canadian Prostate Cancer Research Alliance
2009 - 2015
Project Grants
A more sensitive blood test for prostate cancer
2020 - 2022
The short and long of a GWAS identified long non-coding RNA
2019 - 2021
Dynamic interplay of lipid supply
2019 - 2020
A personalised PSA test for prostate cancer diagnosis
2017 - 2020
Improving the effectiveness of the PSA test
2018 - 2019
Targeting a master regulator of tumour cell plasticity as a new adjuvant therapy for prostate cancer
2016 - 2019
Investigation of the role of lymph node metastasis in initiation and progression of bone metastasis
2018 - 2019
Seahorse XFe96 Analyser
2018 - 2018
Tissue microarrayer
2018 - 2018
Functional and mechanistic characterisation of a novel LncRNA at chromosomal locus 5p15 in prostate cancer
2017 - 2018
High-content screening of small molecule inhibitors from nature that target prostate cancer metabolism
2017 - 2018
Association analysis of microRNA related genetic variations with risk and prognosis of prostate cancer
2017 - 2018
Discovery of new therapeutic targets for aggressive prostate cancer
2018 - 2018
Novel microRNAs as potential targets for treating prostate cancer
2017 - 2017
Exploring the role of miRSNPs in diagnosis and prognosis of prostate cancer
2015 - 2017
Targeting neuropilin-1 to inhibit prostate cancer metastasis and therapy resistance
2015 - 2017
The ghrelin receptor antisense long non-coding RNA gene, GHSROS, as a potential target for prostate cancer therapy
2016 - 2017
High-content screening of small molecule inhibitors from nature that target prostate cancer metabolism
2017 - 2017
Novel microRNAs as potential targets for treating prostate cancer
2017 - 2017
hSSB1: A key regulator of genome stability and potential cancer therapeutic target
2014 - 2016
The ghrelin axis as a target for prostate cancer therapy
2014 - 2016
Development of YB-1 as a therapeutic target in advanced prostate cancer
2015 - 2016
PSA Coding variants: Functional analysis, multiethnic association and risk models for prostate cancer
2015 - 2016
KLK14 as a novel therapeutic target in muscle wasting induced by androgen deprivation therapy
2016 - 2016
Circulating long noncoding RNA as diagnostic and prognostic biomarkers for prostate cancer
2015 - 2016
Characterising insulin signalling in androgen-deprived prostate cancer cells
2014 - 2015
Defining the role of the PSA-related Kallikrein serine proteases in hormone dependent cancer progression
2011 - 2015
Targeting leptin in prostate cancer progression; linking metabolic dysfunction and castrate resistance
2014 - 2015
To study how prostate tumour metastasizes to bone
2012 - 2015
KLK4 is a key regulator of the reactive stromal microenvironment in prostate cancer
2014 - 2015
Identification and characterisation of a genetic signature at the 5p15 region associated with prostate cancer across ethnic groups
2013 - 2015
miSNPs as novel diagnostic and prognostic biomarkers for prostate cancer
2014 - 2015
Endeavour Research Fellowship
2015 - 2015
MyRIP and exosomes function to control genomic stability
2014 - 2015
A new hierarchy of mathematical models to quantify the role of ghrelin during cell invasion
2014 - 2014
Circulating Tumour Cells Collaborative Prostate Cancer Biomarker Project
2013 - 2014
Development of assays for the capture and detection of prostate cancer-derived exosomes and exosomal markers
2013 - 2014
Development of new therapeutic approaches for prostate cancer progression - dissecting the effects of diabetes and obesity in cancer progression
2009 - 2014
Engineering a High-Throughput Prostate Cancer Stem Cell Niche Mimic
2013 - 2014
Exosome biomarkers: Defining prognosis for drug- and castrate-resistant prostate cancer
2012 - 2014
To identify a new therapeutic target for the treatment of prostate cancer
2012 - 2014
Identification of RNA species regulated by YB-1 and G3BPs in prostate cancer cells
2011 - 2012
Navigation
Discovery
Pre-Clinical
Clinical Trials
Health Services
Publications
Software
Presentations 2019
Presentations 2018
Presentations 2017
Presentations 2016
Presentations 2015
Presentations 2014
Presentations 2013
Site Map
Accessibility
Contact